Tradewinds Capital Management, LLC Bristol Myers Squibb CO Transaction History

Tradewinds Capital Management, LLC

  • $372 Million
  • Q3 2024

A detailed history of Tradewinds Capital Management, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Tradewinds Capital Management, LLC holds 1,254 shares of BMY stock, worth $73,020. This represents 0.02% of its overall portfolio holdings.

Number of Shares
1,254
Previous 1,239 1.21%
Holding current value
$73,020
Previous $51,000 25.49%
% of portfolio
0.02%
Previous 0.02%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 16, 2024
BUY
$39.66 - $51.75 $594 - $776
15 Added 1.21%
1,254 $64,000
Q2 2024

Jul 17, 2024
BUY
$40.25 - $52.99 $603 - $794
15 Added 1.23%
1,239 $51,000
Q1 2024

Apr 18, 2024
SELL
$47.98 - $54.4 $575 - $652
-12 Reduced 0.97%
1,224 $66,000
Q4 2023

Jan 31, 2024
BUY
$48.48 - $57.85 $1,793 - $2,140
37 Added 3.09%
1,236 $63,000
Q3 2023

Oct 30, 2023
BUY
$57.89 - $64.73 $578 - $647
10 Added 0.84%
1,199 $69,000
Q2 2023

Jul 20, 2023
BUY
$63.71 - $70.74 $637 - $707
10 Added 0.85%
1,189 $76,000
Q1 2023

Apr 10, 2023
BUY
$65.71 - $74.53 $525 - $596
8 Added 0.68%
1,179 $81,000
Q4 2022

Jan 20, 2023
BUY
$68.48 - $81.09 $479 - $567
7 Added 0.6%
1,171 $0
Q3 2022

Oct 18, 2022
SELL
$0.13 - $76.84 $2 - $1,306
-17 Reduced 1.44%
1,164 $83,000
Q2 2022

Jul 21, 2022
SELL
$72.62 - $79.98 $265,280 - $292,166
-3,653 Reduced 75.57%
1,181 $91,000
Q1 2022

Apr 25, 2022
BUY
$61.48 - $73.72 $553 - $663
9 Added 0.19%
4,834 $353,000
Q4 2021

Feb 02, 2022
SELL
$53.63 - $62.52 $54,434 - $63,457
-1,015 Reduced 17.38%
4,825 $301,000
Q3 2021

Nov 04, 2021
BUY
$59.17 - $69.31 $39,229 - $45,952
663 Added 12.81%
5,840 $346,000
Q2 2021

Jul 30, 2021
BUY
$61.91 - $67.42 $49,961 - $54,407
807 Added 18.47%
5,177 $346,000
Q1 2021

Apr 23, 2021
BUY
$59.34 - $66.74 $474 - $533
8 Added 0.18%
4,370 $276,000
Q4 2020

Feb 10, 2021
BUY
$57.74 - $65.43 $57,740 - $65,430
1,000 Added 29.74%
4,362 $271,000
Q4 2019

Feb 04, 2020
BUY
$49.21 - $64.19 $92,268 - $120,356
1,875 Added 126.09%
3,362 $216,000
Q1 2019

Apr 23, 2019
SELL
$45.12 - $53.8 $31,584 - $37,660
-700 Reduced 32.01%
1,487 $71,000
Q4 2018

Jan 31, 2019
SELL
$48.76 - $63.23 $24,380 - $31,615
-500 Reduced 18.61%
2,187 $114,000
Q3 2018

Oct 31, 2018
SELL
$55.19 - $62.25 $8,278 - $9,337
-150 Reduced 5.29%
2,687 $167,000
Q2 2018

Aug 06, 2018
SELL
$50.53 - $62.98 $11,419 - $14,233
-226 Reduced 7.38%
2,837 $157,000
Q4 2017

Feb 01, 2018
BUY
$59.94 - $65.35 $67,012 - $73,061
1,118 Added 57.48%
3,063 $188,000
Q3 2017

Nov 03, 2017
BUY
$55.23 - $63.74 $107,422 - $123,974
1,945
1,945 $124,000

Others Institutions Holding BMY

# of Institutions
2,533
Shares Held
1.47B
Call Options Held
31.6M
Put Options Held
35M
View Full List

About BRISTOL MYERS SQUIBB CO

BMY Quotes by TradingView
  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $124B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Tradewinds Capital Management, LLC Portfolio

Follow Tradewinds Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tradewinds Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tradewinds Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email